通过体恤护理管理复杂病症

卓越的临床医疗

我们经验丰富的输液专业护理团队致力于开发定制化的护理方案,同时进行持续的临床监测,以管理神经系统疾病(例如肌萎缩性侧索硬化症(ALS)/葛雷克氏症和杜兴氏肌肉营养不良症)的病情发展。这种个性化的护理方法和专门的专家团队可确保根据需要修改输液治疗方法,以减缓肌肉营养不良和萎缩的发展速度。 

覆盖全美的本地服务

As the largest independent infusion therapy provider in the United States, Option Care Health has the national reach and experience to provide a wider access of infusion treatments to the patients who need them most. Options for care at home or at infusion suites provide families and patients the opportunity to seamlessly transition care as needed.

福利

全面的输液疗法护理

在整个输液治疗过程中,我们围绕家人和患者在每一步为他们提供无缝支持

每位患者都应获得安全、个性化的护理

我们的临床团队会根据每位患者的具体需求定制治疗计划,并由指定的护士和药剂师来监控治疗情况。

临床监测和报告

进展报告让处方医师能够在输液治疗的整个过程中随时了解病人的状况。

Exclusive and preferred access to pharmaceuticals

Option Care Health’s pharmaceutical partnerships give providers and patients access to several limited distribution treatments including Radicava®[*]Radicava is registered and owned by Mitsubishi Tanabe Pharma America, Inc. and Exondys®[*]Exondys is registered and owned by Sarepta Therapeutics, Inc.

个性化协调

我们全面的服务可协调从医院到家庭的护理。

获得全天候的患者支持

经验丰富的临床医生和护士可以随时通过电话解答问题,并为患者、家庭和医疗服务提供者提供支持。

输液治疗护理专家

95%1References:
1. January-December 2019 patient satisfaction data. Survey of 9,878 patients.
2. Data on file, Option Care Health
3. January-December 2020, total Option Care Health unique patients serviced.

Overall patient satisfaction

40+

Years of experience providing infusion therapy

2900+2References:
1. January-December 2019 patient satisfaction data. Survey of 9,878 patients.
2. Data on file, Option Care Health
3. January-December 2020, total Option Care Health unique patients serviced.

Multidisciplinary clinicians

220k+3References:
1. January-December 2019 patient satisfaction data. Survey of 9,878 patients.
2. Data on file, Option Care Health
3. January-December 2020, total Option Care Health unique patients serviced.

Patients treated annually